Cardioprotective C-kit+ bone marrow cells attenuate apoptosis after acute myocardial infarction in mice-in-vivo assessment with fluorescence molecular imaging

Theranostics

Volumn 3, Issue 11, 2013, Pages 903-913

  Ale, Angelique ^a   Siebenhaar, Frank ^b   Kosanke, Katja ^c   Aichler, Michaela ^d   Radrich, Karin ^a   Heydrich, Sina ^b   Schiemann, Matthias ^a,d   Bielicki, Isabella ^c   Noel, Peter B ^c   Braren, Rickmer ^c   Maurer, Marcus ^b   Walch, Axel K ^d   Rummeny, Ernst J ^c   Ntziachristos, Vasilis ^a   Wildgruber, Moritz ^a,c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Apoptosis; Heart failure; Imaging; Infarction; Reperfusion

Indexed keywords

LIPOCORTIN 5; STEM CELL FACTOR RECEPTOR;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; CARDIOVASCULAR MAGNETIC RESONANCE; CELL THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; EX VIVO STUDY; FLOW CYTOMETRY; FLUORESCENCE IMAGING; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MOLECULAR IMAGING; MOUSE; NONHUMAN; REPERFUSION INJURY; WILD TYPE; ANIMAL; BIOLOGICAL THERAPY; CHEMISTRY; HEART INFARCTION; IMAGING; INFARCTION; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHYSIOLOGY; PLURIPOTENT STEM CELL; REPERFUSION.;

APOPTOSIS; HEART FAILURE; IMAGING; INFARCTION; REPERFUSION.;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; CELL- AND TISSUE-BASED THERAPY; MAGNETIC RESONANCE IMAGING; MICE; MOLECULAR IMAGING; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; OPTICAL IMAGING; PLURIPOTENT STEM CELLS; PROTO-ONCOGENE PROTEINS C-KIT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84899522283     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.5938     Document Type: Article

References (31)

1. Whelan RS, Kaplinskiy V, Kitsis RN. Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev Physiol. 2010; 72: 19-44. doi:10.1146/annurev.physiol.010908.163111.
2. Foo RS, Mani K, Kitsis RN. Death begets failure in the heart. J Clin Invest. 2005; 115: 565-71. doi:10.1172/JCI24569.
3. Hayakawa K, Takemura G, Kanoh M, Li Y, Koda M, Kawase Y, et al. Inhibition of granulation tissue cell apoptosis during the subacute stage of myocardial infarction improves cardiac remodeling and dysfunction at the chronic stage. Circulation. 2003; 108: 104-9. doi:10.1161/01.CIR.0000074225.62168.68 01.CIR.0000074225.62168.68 [pii].
4. Laflamme MA, Murry CE. Heart regeneration. Nature. 2011; 473: 326-35. doi:nature10147 [pii] 10.1038/nature10147.
5. Fazel S, Tang GH, Angoulvant D, Cimini M, Weisel RD, Li RK, et al. Current status of cellular therapy for ischemic heart disease. Ann Thorac Surg. 2005; 79: S2238-47. doi:S0003-4975(05)00367-X [pii] 10.1016/j.athoracsur.2005.02.085.
6. Cimini M, Fazel S, Zhuo S, Xaymardan M, Fujii H, Weisel RD, et al. c-kit dysfunction impairs myocardial healing after infarction. Circulation. 2007; 116: I77-82. doi:116/11_suppl/I-77 [pii] 10.1161/CIRCULATIONAHA.107.708107.
7. Fazel S, Cimini M, Chen L, Li S, Angoulvant D, Fedak P, et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest. 2006; 116: 1865-77. doi:10.1172/JCI27019.
8. Fazel SS, Chen L, Angoulvant D, Li SH, Weisel RD, Keating A, et al. Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury. FASEB J. 2008; 22: 930-40. doi:fj.07-8636com [pii] 10.1096/fj.07-8636com.
9. Ayach BB, Yoshimitsu M, Dawood F, Sun M, Arab S, Chen M, et al. Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction. Proc Natl Acad Sci U S A. 2006; 103: 2304-9. doi:0510997103 [pii] 10.1073/pnas.0510997103.
10. Schutters K, Reutelingsperger C. Phosphatidylserine targeting for diagnosis and treatment of human diseases. Apoptosis. 2010; 15: 1072-82. doi:10.1007/s10495-010-0503-y.
11. Nahrendorf M, Sosnovik DE, Waterman P, Swirski FK, Pande AN, Aikawa E, et al. Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct. Circ Res. 2007; 100: 1218-25. doi:01.RES.0000265064.46075.31 [pii] 10.1161/01.RES.0000265064.46075.31.
12. Uemura R, Xu M, Ahmad N, Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res. 2006; 98: 1414-21. doi:01.RES.0000225952.61196.39 [pii] 10.1161/01.RES.0000225952.61196.39.
13. Xu M, Uemura R, Dai Y, Wang Y, Pasha Z, Ashraf M. In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. J Mol Cell Cardiol. 2007; 42: 441-8. doi:S0022-2828(06)00964-3 [pii] 10.1016/j.yjmcc.2006.10.009.
14. Dumont EA, Reutelingsperger CP, Smits JF, Daemen MJ, Doevendans PA, Wellens HJ, et al. Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart. Nat Med. 2001; 7: 1352-5. doi:10.1038/nm1201-1352 nm1201-1352 [pii].
15. Xaymardan M, Cimini M, Fazel S, Weisel RD, Lu WY, Martin U, et al. c-Kit function is necessary for in vitro myogenic differentiation of bone marrow hematopoietic cells. Stem Cells. 2009; 27: 1911-20. doi:10.1002/stem.106.
16. Weissleder R, Ntziachristos V. Shedding light onto live molecular targets. Nat Med. 2003; 9: 123-8. doi:10.1038/nm0103-123 nm0103-123 [pii].
17. Ale A, Ermolayev V, Herzog E, Cohrs C, de Angelis MH, Ntziachristos V. FMT-XCT: in vivo animal studies with hybrid fluorescence molecular tomography-X-ray computed tomography. Nat Methods. 2012;9(6):615-20 doi:nmeth.2014 [pii] 10.1038/nmeth.2014.
18. Ale A, Schulz RB, Sarantopoulos A, Ntziachristos V. Imaging performance of a hybrid x-ray computed tomography-fluorescence molecular tomography system using priors. Med Phys. 2010;37: 1976-86.
19. Schulz RB, Ale A, Sarantopoulos A, Freyer M, Soehngen E, Zientkowska M, et al. Hybrid system for simultaneous fluorescence and x-ray computed tomography. IEEE Trans Med Imaging. 2010; 29: 465-73. doi:10.1109/TMI.2009.2035310.
20. Freyer M, Ale A, Schulz RB, Zientkowska M, Ntziachristos V, Englmeier KH. Fast automatic segmentation of anatomical structures in x-ray computed tomography images to improve fluorescence molecular tomography reconstruction. J Biomed Opt. 2010; 15: 036006. doi:10.1117/1.3431101.
21. Christen T, Nahrendorf M, Wildgruber M, Swirski FK, Aikawa E, Waterman P, et al. Molecular imaging of innate immune cell function in transplant rejection. Circulation. 2009; 119: 1925-32. doi:CIRCULATIONAHA.108.796888 [pii] 10.1161/CIRCULATIONAHA.108.796888.
22. Laufer EM, Reutelingsperger CP, Narula J, Hofstra L. Annexin A5: an imaging biomarker of cardiovascular risk. Basic Res Cardiol. 2008; 103: 95-104. doi:10.1007/s00395-008-0701-8.
23. Sun J, Li SH, Liu SM, Wu J, Weisel RD, Zhuo YF, et al. Improvement in cardiac function after bone marrow cell thearpy is associated with an increase in myocardial inflammation. American journal of physiology Heart and circulatory physiology. 2009; 296: H43-50. doi:10.1152/ajpheart.00613.2008.
24. Altarche-Xifro W, Curato C, Kaschina E, Grzesiak A, Slavic S, Dong J, et al. Cardiac c-kit+AT2+ cell population is increased in response to ischemic injury and supports cardiomyocyte performance. Stem Cells. 2009; 27: 2488-97. doi:10.1002/stem.171.
25. Xiang FL, Lu X, Hammoud L, Zhu P, Chidiac P, Robbins J, et al. Cardiomyocyte-specific overexpression of human stem cell factor improves cardiac function and survival after myocardial infarction in mice. Circulation. 2009; 120: 1065-74. doi:CIRCULATIONAHA.108.839068 [pii] 10.1161/CIRCULATIONAHA.108.839068.
26. Lutz M, Rosenberg M, Kiessling F, Eckstein V, Heger T, Krebs J, et al. Local injection of stem cell factor (SCF) improves myocardial homing of systemically delivered c-kit + bone marrow-derived stem cells. Cardiovasc Res. 2008; 77: 143-50. doi:cvm027 [pii] 10.1093/cvr/cvm027.
27. Ferreira-Martins J, Ogorek B, Cappetta D, Matsuda A, Signore S, D'Amario D, et al. Cardiomyogenesis in the developing heart is regulated by c-kit-positive cardiac stem cells. Circ Res. 2012; 110: 701-15. doi:10.1161/CIRCRESAHA.111.259507.
28. Limana F, Germani A, Zacheo A, Kajstura J, Di Carlo A, Borsellino G, et al. Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res. 2005; 97: e73-83. doi:10.1161/01.RES.0000186276.06104.04.
29. Gude N, Muraski J, Rubio M, Kajstura J, Schaefer E, Anversa P, et al. Akt promotes increased cardiomyocyte cycling and expansion of the cardiac progenitor cell population. Circ Res. 2006; 99: 381-8. doi:10.1161/01.RES.0000236754.21499.1c.
30. Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation. 2004; 109: 1615-22. doi:10.1161/01.CIR.0000124476.32871.E3 01.CIR.0000124476.32871.E3 [pii].
31. Leuschner F, Nahrendorf M. Molecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinic. Circ Res. 2011; 108: 593-606. doi:108/5/593 [pii] 10.1161/CIRCRESAHA.110.232678.